| Douglas L Dier, MD | |
|
98 Allen St, Rutland, VT 05701-4592 | |
| (802) 775-3374 | |
| Not Available |
| Full Name | Douglas L Dier |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 39 Years |
| Location | 98 Allen St, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548374382 | NPI | - | NPPES |
| 0009586 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | 042-0007797 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rutland Regional Medical Center | Rutland, VT | Hospital |
| Porter Hospital, Inc | Middlebury, VT | Hospital |
| Entity Name | Douglas L. Dier, M.d., P.c |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275845943 PECOS PAC ID: 8628192218 Enrollment ID: O20100903000225 |
News Archive
Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
A new treatment for patients with chronic myeloid leukemia (CML) - a disorder marked by an overproduction of white blood cells - yields positive results in those who have relapsed on imatinib, the standard treatment for the disease, according to a Phase I study to be presented today at the 46th Annual Meeting of the American Society of Hematology (ASH).
Colorectal cancer is a malignant neoplasm affecting the large bowel and the rectum mainly after the 5th decade of life and representing the second cause of death for cancer in western countries (the third in women). In about 15-20% of patients there is an inherited predisposition.
Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase. Caspase inhibitors have therapeutic potential to treat and prevent apoptosis-mediated liver injury, and some are currently in clinical trials.
During the next three years, researchers at Case Western Reserve University will team with NASA Glenn Research Center and firefighters nationally, from Cleveland to Oregon, to design and test sensors aimed at protecting firefighters from respiratory damage and illnesses.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Douglas L Dier, MD 98 Allen St Ste 4, Rutland, VT 05701-4776 Ph: (802) 775-3374 | Douglas L Dier, MD 98 Allen St, Rutland, VT 05701-4592 Ph: (802) 775-3374 |
News Archive
Survival rates for elderly patients who received stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) rose from roughly 40 to 60 percent over the past decade, concurrent with the increasing adoption of SBRT, according to research presented today at the 58th Annual Meeting of the American Society for Radiation Oncology.
A new treatment for patients with chronic myeloid leukemia (CML) - a disorder marked by an overproduction of white blood cells - yields positive results in those who have relapsed on imatinib, the standard treatment for the disease, according to a Phase I study to be presented today at the 46th Annual Meeting of the American Society of Hematology (ASH).
Colorectal cancer is a malignant neoplasm affecting the large bowel and the rectum mainly after the 5th decade of life and representing the second cause of death for cancer in western countries (the third in women). In about 15-20% of patients there is an inherited predisposition.
Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase. Caspase inhibitors have therapeutic potential to treat and prevent apoptosis-mediated liver injury, and some are currently in clinical trials.
During the next three years, researchers at Case Western Reserve University will team with NASA Glenn Research Center and firefighters nationally, from Cleveland to Oregon, to design and test sensors aimed at protecting firefighters from respiratory damage and illnesses.
› Verified 6 days ago
Michael William Gleeson, MD, PHD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1 Albert Cree Dr, Rutland, VT 05701 Phone: 802-786-1400 Fax: 802-786-1405 | |
Sudhir Babu Movva, M.D Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-747-1633 Fax: 802-775-7214 | |
T Ray Lovko, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 215 Stratton Rd, Rutland, VT 05701 Phone: 802-773-3386 Fax: 802-773-4578 | |
Dr. Louis Block Meyers, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 Fax: 802-772-2556 | |
William Orourke, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 69 Allen St, Suite 11, Rutland, VT 05701 Phone: 802-775-0033 | |
Mark C Stickney, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Commons St, Rutland, VT 05701 Phone: 802-773-7155 Fax: 802-773-7616 | |
Dr. Mark Edward Logan, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 199 Stratton Rd, Rutland, VT 05701 Phone: 802-775-7798 |